09886 叮噹健康
DINGDANG HEALTH
DINGDANG HEALTH
| Listing Date | 2022/09/14 |
| Listing Price | 12.000 |
Quote
Subscription Result
- Subscription Rate7.20x
- Guarantee One Lot Size10 lot
- One Lot Success Rate11.22%
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
Dingdang Health Technology Group is a service provider in providing express digital healthcare services in China, since its inception in 2014. It is operating on-demand pharmaceutical retail and medical consultation, primarily with online-to-offline solutions, including operations related to its online platforms, offline smart pharmacies and express delivery service.
The Group is a service provider in the digital retail pharmacy industry in China and ranked No. 3 in such industry by revenue in 2021 with a market share of 1.0%, according to the Frost & Sullivan Report. It is also the largest product and service provider in the on-demand digital pharmacy industry in China by revenue in 2021 with a market share of 6.8%
Its drug express service offering is mainly operated through online direct sales channel, in which the Group sells products directly to users. As of 23 Aug 2022, the Group has established a network of 351 smart pharmacies across 17 cities in China. It focuses on express delivery, on-demand digital pharmacies aim to provide last-mile delivery service for users to purchase medicines and usually deliver medicines within 30 minutes to users after orders placed.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 500 |
GLOBAL OFFERING
| No. of Offer Shares | 33.54M shares |
| No. of International Offer Shares | 30.18M shares |
| No. of HK Offer Shares | 3.35M shares |
| Offer Price | $12.00 |
| Stock Code | 9886 |
| Sponsor(s) | China International Capital Corporation Hong Kong Securities Limited, CMB International Capital Limited |
| Underwriter(s) | China International Capital Corporation Hong Kong Securities Limited, CMB International Capital Limited, Futu Securities International (Hong Kong) Limited, Silverbricks Securities Company Limited |
TIME TABLE
| Application Period | Sep 01 (Thu) - noon, Sep 06 (Tue) |
| Price Determination Date | -- |
| Result Announcement Date | On or before Sep 13 (Tue) |
| Result Announcement Date | On or before Sep 13 (Tue) |
| Dealings in Shares commence on | Sep 14, 2022. (Wed) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 15X - 50X | 50X - 100X | Over 100X |
| % of total shares reallocated to HK Offer | 30% | 40% | 50% |
Sales Statistics (HKD)
| Offer Price | $12.00 |
| Capitalization | 16.10B |
| NAV / share ($) | $-5.2 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 12.00, the net proceeds raised would be HKD 341.60M, of which |
| 45% : Business expansion such as the further development of smart pharmacy network, and enhancement of user growth and engagement |
| 15% : Optimizing technology systems and operating platforms |
| 10% : Upgrading services and business such as building professional structure of full-time doctors and pharmacists |
| 20% : For potential investments and acquisitions or strategic alliances |
| 10% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).